Journal

Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021

Informations de publication

Date de publication:
2020
Historique:
received: 29 08 2019
revised: 05 12 2019
accepted: 14 12 2019
entrez: 9 5 2020
pubmed: 10 5 2020
medline: 10 5 2020
Statut: epublish

Résumé

Gouty arthritis is an inflammatory joint disease closely related to hyperuricemia. It is characterized by deposition of monosodium urate crystals in the joints, resulting in an intense inflammatory process and pain. Control of hyperuricemia and anti-inflammation treatments are the main therapeutic approaches. However, the commonly used drugs for inhibiting uric acid and acute gouty arthritis have obvious gastrointestinal and renal toxicity; thus, there is an urgency to develop new alternative therapeutic drugs. An extract of

Identifiants

pubmed: 32382282
doi: 10.1155/2020/3095624
pmc: PMC7193269
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3095624

Informations de copyright

Copyright © 2020 Rongmei Yao et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Nephrol Dial Transplant. 2015 Aug;30(8):1370-6
pubmed: 25813275
Ther Adv Musculoskelet Dis. 2016 Aug;8(4):145-59
pubmed: 27493693
Front Pharmacol. 2018 Sep 25;9:1076
pubmed: 30319413
Immunol Cell Biol. 2010 Jan;88(1):20-3
pubmed: 19935768
Trends Mol Med. 2017 Aug;23(8):756-768
pubmed: 28732688
Exp Ther Med. 2014 Dec;8(6):1683-1688
pubmed: 25371715
Hip Pelvis. 2017 Dec;29(4):211-222
pubmed: 29250494
Eur J Pharmacol. 2014 Oct 5;740:321-8
pubmed: 25064339
Am J Kidney Dis. 1999 Nov;34(5):E20
pubmed: 10561160
Arthritis Rheum. 2010 Jul;62(7):2170-9
pubmed: 20506351
Phytomedicine. 2018 Mar 15;42:9-17
pubmed: 29655702
Curr Opin Rheumatol. 2015 Mar;27(2):156-63
pubmed: 25633244
Arch Orthop Trauma Surg. 2011 Mar;131(3):429-35
pubmed: 21190029
Eur J Pharmacol. 2016 Sep 5;786:116-127
pubmed: 27268719
Arthritis Rheum. 2003 Aug;48(8):2310-20
pubmed: 12905486
Nat Rev Rheumatol. 2014 May;10(5):271-83
pubmed: 24614592
J Rheumatol. 2008 Mar;35(3):498-501
pubmed: 18260174
Invest Clin. 2011 Mar;52(1):15-22
pubmed: 21612136
Cell Biochem Funct. 2014 Jan;32(1):106-14
pubmed: 23674350
Semin Immunopathol. 2013 Jul;35(4):501-12
pubmed: 23344781
Curr Opin Rheumatol. 2014 Mar;26(2):186-91
pubmed: 24419750
Arthritis Res Ther. 2010;12(6):223
pubmed: 21205285
Evid Based Complement Alternat Med. 2012;2012:967573
pubmed: 23304232
Nat Med. 2016 Dec 6;22(12):1382-1384
pubmed: 27923029
J Ethnopharmacol. 2012 Aug 1;142(3):845-50
pubmed: 22732730
Clin Chem. 1971 Mar;17(3):158-60
pubmed: 5543187
Agents Actions. 1991 Sep;34(1-2):38-41
pubmed: 1793049
Arthritis Rheum. 2007 Oct;56(10):3183-8
pubmed: 17907163
J Biol Regul Homeost Agents. 2019 Jan 30;33(1):63-71
pubmed: 30697988
Immunol Cell Biol. 2010 Jan;88(1):32-40
pubmed: 19949421
J Inflamm Res. 2011;4:39-49
pubmed: 22096368
Curr Rheumatol Rep. 2011 Apr;13(2):160-6
pubmed: 21234729
PLoS One. 2015 Dec 28;10(12):e0145093
pubmed: 26709520
J Pharm Pharmacol. 2012 Aug;64(8):1119-27
pubmed: 22775215
J Ethnopharmacol. 2013 Nov 25;150(2):545-52
pubmed: 24060409
Inflammation. 2011 Jun;34(3):184-92
pubmed: 20495860

Auteurs

Rongmei Yao (R)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
College of Traditional Chinese Medicine, North China University of Sciences and Technology, Tangshan 063210, China.

Zihan Geng (Z)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Xin Mao (X)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Yanyan Bao (Y)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Shanshan Guo (S)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Lei Bao (L)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Jing Sun (J)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Yingjie Gao (Y)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Yingli Xu (Y)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Bo Guo (B)

Department of Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou 450003, China.

Fengxian Meng (F)

Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China.

Xiaolan Cui (X)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Classifications MeSH